Morphology of the bone marrow, spleen and liver during hematopoietic cell mobilization with cyclophosphamide in mice.
Cyclophosphamide (CY), the agent with cytoreductive activity, is widely exploited in cancer chemotherapy, and can be used alone or in combination with various cytokines and growth factors to stimulate the egress of hematopoietic stem/progenitor cells (HSPC) from the BM compartment. The aim of the pr...
Main Authors: | Barbara Wiszniewska, Ryszard Grzegrzółka, Mariola Marchlewicz, Paweł Szumilas, Anna Karbicka, Kamila Barcew, Bogusław Machaliński |
---|---|
Format: | Article |
Language: | English |
Published: |
Via Medica
2009-01-01
|
Series: | Folia Histochemica et Cytobiologica |
Online Access: | http://czasopisma.viamedica.pl/fhc/article/view/4404 |
Similar Items
-
Ginsenoside Rg1 improves bone marrow hematopoietic activity in cyclophosphamide-induced myelosuppression mice viaextramedullary hematopoiesis of the spleen
by: Chen, Fei-Peng, et al.
Published: (2015) -
Protective Effect of Royal Jelly against Cyclophosphamide-Induced Thrombocytopenia and Spleen and Bone Marrow Damages in Rats
by: Fatemeh Khazaei, et al.
Published: (2020-01-01) -
Non-Hematopoietic and Hematopoietic SIRPα Signaling Differently Regulates Murine B Cell Maturation in Bone Marrow and Spleen.
by: Shrikant Shantilal Kolan, et al.
Published: (2015-01-01) -
The Hematopoietic Bone Marrow Niche Ecosystem
by: Julia Fröbel, et al.
Published: (2021-07-01) -
Effects of Visceralising Leishmania on the Spleen, Liver, and Bone Marrow: A Pathophysiological Perspective
by: Aikaterini Poulaki, et al.
Published: (2021-04-01)